ALBANY MOLECULAR SIGNS LICENSING AGREEMENT.(BUSINESS)

Byline: Staff report

ALBANY -- Albany Molecular Research Inc. has signed a renewable, two-year licensing agreement with IntraBiotics Pharmaceuticals Inc. to develop anti-infective therapies.

Under the agreement, IntraBiotics of Mountain View, Calif., will use Albany Molecular's drug discovery library containing more than 100,000 natural compounds to identify compounds that demonstrate antimicrobial or antifungal characteristics.

Albany Molecular will receive technology-access fees, research …